12:00 AM
 | 
Jun 24, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Protalix, Oswaldo Cruz Foundation (Fiocruz) sales and marketing update

Protalix will supply the foundation, which is a part of the Brazil Ministry of Health, with the company's Gaucher's disease drug Uplyso alfataliglicerase. Under the seven-year deal, Protalix will transfer to Fiocruz the capacity and skills required for the Brazilian government to develop its own manufacturing facility to produce Uplyso. Fiocruz will purchase up to $40 million worth of Uplyso in the...

Read the full 296 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >